What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

galapagos lizard

Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping)

Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments?

Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?

Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government

Friday: Merck relinquishes Rare Disease license to instead focus on Immuno-oncology

Weekend: We will celebrate German unity on Saturday.


Explore other topics: AbbVieCRISPRGalapagosMerckRoche

Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

This field is for validation purposes and should be left unchanged.

Suggested Articles

Show More